1978 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1978 2019

Filter
Article
2019

A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

Research output: Contribution to journalArticle

Glioma
Karnofsky Performance Status
Bevacizumab
Multicenter Studies
Adrenal Cortex Hormones

A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 1 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

Research output: Contribution to journalArticle

Glioma
Karnofsky Performance Status
Bevacizumab
Multicenter Studies
Adrenal Cortex Hormones

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Landi, L., D'Incà, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1

Research output: Contribution to journalArticle

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Landi, L., D'Incà, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., Nov 21 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Immunotherapy
Neoplasm Metastasis
Bone and Bones
Immune System

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Landi, L., D'Incà, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1

Research output: Contribution to journalArticle

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer: Journal for ImmunoTherapy of Cancer

Landi, L., D'Incà, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., 2019, In : J. Immunother. Cancer. 7, 1

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Immunotherapy
Neoplasm Metastasis
Bone and Bones
Neoplasms

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Landi, L., D'IncÃ, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, p. 316 1 p.

Research output: Contribution to journalArticle

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Landi, L., D'Incà, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., Nov 21 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 316.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Immunotherapy
Neoplasm Metastasis
Bone and Bones
Disease-Free Survival
Adjuvant Chemotherapy
Breast Neoplasms
Drug Therapy
Disease-Free Survival
Survival

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

Lambertini, M., Poggio, F., Bruzzone, M., Conte, B., Bighin, C., de Azambuja, E., Giuliano, M., De Laurentiis, M., Cognetti, F., Fabi, A., Bisagni, G., Durando, A., Turletti, A., Urracci, Y., Garrone, O., Puglisi, F., Montemurro, F., Ceppi, M., Del Mastro, L. & investigators, GIM., 2019, In : International Journal of Cancer.

Research output: Contribution to journalArticle

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

Lambertini, M., Poggio, F., Bruzzone, M., Conte, B., Bighin, C., de Azambuja, E., Giuliano, M., De Laurentiis, M., Cognetti, F., Fabi, A., Bisagni, G., Durando, A., Turletti, A., Urracci, Y., Garrone, O., Puglisi, F., Montemurro, F., Ceppi, M., Del Mastro, L. & investigators, GIM., Nov 13 2019, In : International Journal of Cancer. p. 10.1002/ijc.32789 10 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Breast Neoplasms
Drug Therapy
Disease-Free Survival
Survival

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

Lambertini, M., Poggio, F., Bruzzone, M., Conte, B., Bighin, C., de Azambuja, E., Giuliano, M., De Laurentiis, M., Cognetti, F., Fabi, A., Bisagni, G., Durando, A., Turletti, A., Urracci, Y., Garrone, O., Puglisi, F., Montemurro, F., Ceppi, M., Del Mastro, L. & investigators, O. B. O. T. GIM., Nov 13 2019, In : Int. J. Cancer.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Breast Neoplasms
Drug Therapy
Disease-Free Survival
Survival

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., Marinis, F. D. E., Sperandi, F., Piantedosi, F., Vitali, M., Soto Parra, H. J., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., Jan 1 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Patient Safety
Non-Small Cell Lung Carcinoma
Central Nervous System
Neoplasm Metastasis
Confidence Intervals

Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., DE Marinis, F., Sperandi, F., Piantedosi, F., Vitali, M., Parra, H. J. S., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., Aug 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Patient Safety
Non-Small Cell Lung Carcinoma
Central Nervous System
Neoplasm Metastasis
Confidence Intervals

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., Marinis, F. D. E., Sperandi, F., Piantedosi, F., Vitali, M., Soto Parra, H. J., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases: Anticancer Research

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., Marinis, F. D. E., Sperandi, F., Piantedosi, F., Vitali, M., Soto Parra, H. J., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., 2019, In : Anticancer Res.. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Patient Safety
Non-Small Cell Lung Carcinoma
Central Nervous System
Neoplasm Metastasis
Research

Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., DE Marinis, F., Sperandi, F., Piantedosi, F., Vitali, M., Parra, H. J. S., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., Giannarelli, D. & 2 others, Colonese, F. & Delmonte, A., 2019, In : Anticancer Research. 39, 8, p. 4265-4271 7 p.

Research output: Contribution to journalArticle

Phase II study of weekly carboplatin in pretreated adult malignant gliomas

Villani, V., Pace, A., Vidiri, A., Tanzilli, A., Sperati, F., Terrenato, I., Mariantonia, C., Casini, B., Metro, G., Maschio, M., Tatiana, K., Cognetti, F. & Fabi, A., Aug 15 2019, In : Journal of Neuro-Oncology. 144, 1, p. 211-216 6 p.

Research output: Contribution to journalArticle

Carboplatin
Glioma
Intravenous Administration
temozolomide
Disease-Free Survival

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., Jul 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Neutropenia
Ovarian Neoplasms
Drug Therapy
Neoplasms
Therapeutics

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology. 154, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Pten as a prognostic/predictive biomarker in cancer: An unfulfilled promise?

Bazzichetto, C., Conciatori, F., Pallocca, M., Falcone, I., Fanciulli, M., Cognetti, F., Milella, M. & Ciuffreda, L., Apr 2019, In : Cancers. 11, 4, 435.

Research output: Contribution to journalArticle

Open Access
Tumor Biomarkers
Biomarkers
Neoplasms
Phosphatidylinositol 3-Kinase
Chromosomes, Human, Pair 10

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer

Grossi, F., Genova, C., Crinò, L., Delmonte, A., Turci, D., Signorelli, D., Passaro, A., Soto Parra, H., Catino, A., Landi, L., Gelsomino, F., Tiseo, M., Puppo, G., Roila, F., Ricciardi, S., Tonini, G., Cognetti, F., Toschi, L., Tassinari, D., Scoppola, A. & 2 others, Giannarelli, D. & Cortesi, E., Oct 28 2019, In : European Journal of Cancer. 123, p. 72-80 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Population
Survival
Central Nervous System
Neoplasm Metastasis

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer

Grossi, F., Genova, C., Crinò, L., Delmonte, A., Turci, D., Signorelli, D., Passaro, A., Soto Parra, H., Catino, A., Landi, L., Gelsomino, F., Tiseo, M., Puppo, G., Roila, F., Ricciardi, S., Tonini, G., Cognetti, F., Toschi, L., Tassinari, D., Scoppola, A. & 2 others, Giannarelli, D. & Cortesi, E., 2019, In : European Journal of Cancer. 123, p. 72-80 9 p.

Research output: Contribution to journalArticle

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non–small cell lung cancer

Grossi, F., Genova, C., Crinò, L., Delmonte, A., Turci, D., Signorelli, D., Passaro, A., Soto Parra, H., Catino, A., Landi, L., Gelsomino, F., Tiseo, M., Puppo, G., Roila, F., Ricciardi, S., Tonini, G., Cognetti, F., Toschi, L., Tassinari, D., Scoppola, A. & 2 others, Giannarelli, D. & Cortesi, E., Dec 1 2019, In : European Journal of Cancer. 123, p. 72-80 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Population
Survival
Central Nervous System
Neoplasm Metastasis

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non–small cell lung cancer

Grossi, F., Genova, C., Crinò, L., Delmonte, A., Turci, D., Signorelli, D., Passaro, A., Soto Parra, H., Catino, A., Landi, L., Gelsomino, F., Tiseo, M., Puppo, G., Roila, F., Ricciardi, S., Tonini, G., Cognetti, F., Toschi, L., Tassinari, D., Scoppola, A. & 2 others, Giannarelli, D. & Cortesi, E., 2019, In : European Journal of Cancer. 123, p. 72-80 9 p.

Research output: Contribution to journalArticle

Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non–small cell lung cancer: European Journal of Cancer

Grossi, F., Genova, C., Crinò, L., Delmonte, A., Turci, D., Signorelli, D., Passaro, A., Soto Parra, H., Catino, A., Landi, L., Gelsomino, F., Tiseo, M., Puppo, G., Roila, F., Ricciardi, S., Tonini, G., Cognetti, F., Toschi, L., Tassinari, D., Scoppola, A. & 2 others, Giannarelli, D. & Cortesi, E., 2019, In : Eur. J. Cancer. 123, p. 72-80 9 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Population
Neoplasms
Survival
Central Nervous System

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: The Italian expanded access program

Verzoni, E., Cartenì, G., Cortesi, E., Giannarelli, D., De Giglio, A., Sabbatini, R., Buti, S., Rossetti, S., Cognetti, F., Rastelli, F., Sobrero, A., Turci, D., Sternberg, C. N., Porta, C., Cappuzzo, F., Tortora, G., Tassinari, D., Panni, S., Pazzola, A., Surico, G. & 3 others, Raimondi, A., De Giorgi, U. & Procopio, G., Apr 3 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 99.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Drug-Related Side Effects and Adverse Reactions
Safety
Survival
Logistic Models

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

Verzoni, E., Carteni, G., Cortesi, E., Giannarelli, D., De Giglio, A., Sabbatini, R., Buti, S., Rossetti, S., Cognetti, F., Rastelli, F., Sobrero, A., Turci, D., Sternberg, C. N., Porta, C., Cappuzzo, F., Tortora, G., Tassinari, D., Panni, S., Pazzola, A., Surico, G. & 4 others, Raimondi, A., De Giorgi, U., Procopio, G. & group, I. N. R. C. C. E. A. P., 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1

Research output: Contribution to journalArticle

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: The Italian expanded access program

Verzoni, E., Cartenì, G., Cortesi, E., Giannarelli, D., De Giglio, A., Sabbatini, R., Buti, S., Rossetti, S., Cognetti, F., Rastelli, F., Sobrero, A., Turci, D., Sternberg, C. N., Porta, C., Cappuzzo, F., Tortora, G., Tassinari, D., Panni, S., Pazzola, A., Surico, G. & 3 others, Raimondi, A., De Giorgi, U. & Procopio, G., 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1

Research output: Contribution to journalArticle

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: The Italian expanded access program

Verzoni, E., Cartenì, G., Cortesi, E., Giannarelli, D., De Giglio, A., Sabbatini, R., Buti, S., Rossetti, S., Cognetti, F., Rastelli, F., Sobrero, A., Turci, D., Sternberg, C. N., Porta, C., Cappuzzo, F., Tortora, G., Tassinari, D., Panni, S., Pazzola, A., Surico, G. & 3 others, Raimondi, A., De Giorgi, U. & Procopio, G., 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1

Research output: Contribution to journalArticle

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

De Giorgi, U., Cartenì, G., Giannarelli, D., Basso, U., Galli, L., Cortesi, E., Caserta, C., Pignata, S., Sabbatini, R., Bearz, A., Buti, S., Lo Re, G., Berruti, A., Bracarda, S., Cognetti, F., Rastelli, F., Fornarini, G., Porta, C., Turci, D., Sternberg, C. N. & 2 others, Procopio, G. & Group, I. N. R. C. C. E. A. P., Jan 2019, In : BJU International. 123, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Safety
Neoplasm Metastasis
Bone and Bones
Brain

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

De Giorgi, U., Cartenì, G., Giannarelli, D., Basso, U., Galli, L., Cortesi, E., Caserta, C., Pignata, S., Sabbatini, R., Bearz, A., Buti, S., Lo Re, G., Berruti, A., Bracarda, S., Cognetti, F., Rastelli, F., Fornarini, G., Porta, C., Turci, D., Sternberg, C. N. & 30 others, Procopio, G., Falcone, A., Roila, F., Cascinu, S., Tirelli, U., Giustini, L., Sobrero, A., Cappuzzo, F., Tassinari, D., Passalacqua, R., Pazzola, A., Surico, G., Maio, M., Benedetti, G., Barone, C., Spada, M., Tonini, G., Pinto, C., Ciuffreda, L., Scotti, V., Crinò, L., Marchetti, P., Scoppola, A., Favaretto, A., Mattioli, R., Bernardo, A., Di Lieto, M., Moroni, M., Lorusso, V. & Santoro, A., 2019, In : BJU International. 123, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme: BJU International

De Giorgi, U., Cartenì, G., Giannarelli, D., Basso, U., Galli, L., Cortesi, E., Caserta, C., Pignata, S., Sabbatini, R., Bearz, A., Buti, S., Lo Re, G., Berruti, A., Bracarda, S., Cognetti, F., Rastelli, F., Fornarini, G., Porta, C., Turci, D., Sternberg, C. N. & 81 others, Procopio, G., Falcone, A., Roila, F., Cascinu, S., Tirelli, U., Giustini, L., Sobrero, A., Cappuzzo, F., Tassinari, D., Passalacqua, R., Pazzola, A., Surico, G., Maio, M., Benedetti, G., Barone, C., Adamo, V., Ricevuto, E., De Censi, A., Spada, M., Tonini, G., Pinto, C., Ciuffreda, L., Ruggeri, E. M., Bengala, C., Scotti, V., Fagnani, D., Bonetti, A., Mitterer, M., Castiglione, F., Bidoli, P., Ferraù, F., Crinò, L., Frassoldati, A., Marchetti, P., Mini, E., Scoppola, A., Verusio, C., Favaretto, A., Di Costanzo, F., Fasola, G., Merlano, M., Artioli, F., Di Leo, A., Romito, S., Maestri, A., Giannitto Giorgio, C., Ionta, M. T., Verderame, F., Zampa, G., Numico, G., Minelli, M., Tagliaferri, P., Foa, P., Palmiotti, G., De Placido, S., Mattioli, R., Iuliano, F., Defraia, E., Siena, S., Clerico, M., Salvagno, L., Ceresoli, G. L., Bernardo, A., Di Lieto, M., Moroni, M., Maisano, M., Scartozzi, M., Scagliotti, G., Sorarù, M., Pepe, S., Scaltriti, A., Gebbia, V., Testa, E., Lorusso, V., Bordonaro, R., De Signoribus, G., Tedde, N., Santoro, A., Francini, G., Aondio, G. & Group, T. I. N. R. C. C. E. A. P., 2019, In : HSB International. 123, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

De Giorgi, U., Cartenì, G., Giannarelli, D., Basso, U., Galli, L., Cortesi, E., Caserta, C., Pignata, S., Sabbatini, R., Bearz, A., Buti, S., Lo Re, G., Berruti, A., Bracarda, S., Cognetti, F., Rastelli, F., Fornarini, G., Porta, C., Turci, D., Sternberg, C. N. & 81 others, Procopio, G., Falcone, A., Roila, F., Cascinu, S., Tirelli, U., Giustini, L., Sobrero, A., Cappuzzo, F., Tassinari, D., Passalacqua, R., Pazzola, A., Surico, G., Maio, M., Benedetti, G., Barone, C., Adamo, V., Ricevuto, E., De Censi, A., Spada, M., Tonini, G., Pinto, C., Ciuffreda, L., Ruggeri, E. M., Bengala, C., Scotti, V., Fagnani, D., Bonetti, A., Mitterer, M., Castiglione, F., Bidoli, P., Ferraù, F., Crinò, L., Frassoldati, A., Marchetti, P., Mini, E., Scoppola, A., Verusio, C., Favaretto, A., Di Costanzo, F., Fasola, G., Merlano, M., Artioli, F., Di Leo, A., Romito, S., Maestri, A., Giannitto Giorgio, C., Ionta, M. T., Verderame, F., Zampa, G., Numico, G., Minelli, M., Tagliaferri, P., Foa, P., Palmiotti, G., De Placido, S., Mattioli, R., Iuliano, F., Defraia, E., Siena, S., Clerico, M., Salvagno, L., Ceresoli, G. L., Bernardo, A., Di Lieto, M., Moroni, M., Maisano, M., Scartozzi, M., Scagliotti, G., Sorarù, M., Pepe, S., Scaltriti, A., Gebbia, V., Testa, E., Lorusso, V., Bordonaro, R., De Signoribus, G., Tedde, N., Santoro, A., Francini, G., Aondio, G. & Group, T. I. N. R. C. C. E. A. P., 2019, In : BJU International. 123, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

Should all patients with HR-positive HER2-negative metastatic breast cancer receive CDK 4/6 inhibitor as first-line based therapy? A network meta-analysis of data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT trials

Rossi, V., Berchialla, P., Giannarelli, D., Nisticò, C., Ferretti, G., Gasparro, S., Russillo, M., Catania, G., Vigna, L., Mancusi, R. L., Bria, E., Montemurro, F., Cognetti, F. & Fabi, A., Nov 2019, In : Cancers. 11, 11

Research output: Contribution to journalArticle

Open Access
Cyclin-Dependent Kinase 4
Cyclin D
Aromatase Inhibitors
Breast Neoplasms
Disease-Free Survival

Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study

Procopio, G., Apollonio, G., Cognetti, F., Miceli, R., Milella, M., Mosca, A., Chiuri, V. E., Bearz, A., Morelli, F., Ortega, C., Atzori, F., Donini, M., Ratta, R., Raimondi, A., Claps, M., Martinetti, A., Capitanio, U., de Braud, F. G., Cappelletti, V. & Verzoni, E., Nov 1 2019, In : European urology oncology. 2, 6, p. 699-707 9 p.

Research output: Contribution to journalArticle

Metastasectomy
Renal Cell Carcinoma
Observation
Survival
Recurrence

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial

Ascierto, P. A., Long, G. V., Robert, C., Brady, B., Dutriaux, C., Di Giacomo, A. M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., Savage, K. J., Hernberg, M. M., Lebbe, C., Charles, J., Mihalcioiu, C., Chiarion-Sileni, V., Mauch, C., Cognetti, F., Ny, L. & 8 others, Arance, A., Svane, I. M., Schadendorf, D., Gogas, H., Saci, A., Jiang, J., Rizzo, J. & Atkinson, V., 2019, In : JAMA oncology. 5, 2, p. 187-194 8 p.

Research output: Contribution to journalArticle

Multicenter Studies
Observational Studies
Breast Neoplasms
Disease-Free Survival
Survival

T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study

Conte, B., Fabi, A., Poggio, F., Blondeaux, E., Dellepiane, C., D’Alonzo, A., Buono, G., Arpino, G., Magri, V., Naso, G., Presti, D., Mura, S., Fontana, A., Cognetti, F., Molinelli, C., Pastorino, S., Bighin, C., Miglietta, L., Boccardo, F., Lambertini, M. & 1 others, Del Mastro, L., 2019, In : Clinical Breast Cancer. p. S1526820919306718

Research output: Contribution to journalArticle

The unmet need for oncofertility preservation in women: Results of a survey by different oncological specialists in Lazio, Italy

Fabi, A., Lanzetta, G., Vizza, E., Corsi, D., Moscetti, L., Spinelli, G., Mentuccia, L., Lalle, M., Perrone, M., Baiocco, L., Falcicchio, C., Milani, A., Giannarelli, D., Cognetti, F. & Pugliese, P., Dec 2019, In : Current Problems in Cancer. 43, 6, 100479.

Research output: Contribution to journalArticle

Fertility Preservation
Italy
Referral and Consultation
Health Personnel
Infertility
2018

Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?

Catania, G., Malaguti, P., Gasparro, S., Cognetti, F., Vidiri, A. & Fabi, A., Jul 1 2018, In : Oncology (Switzerland). 94, p. 29-33 5 p.

Research output: Contribution to journalArticle

eribulin
Breast Neoplasms
Neoplasm Metastasis
Brain
Radiotherapy
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Placido, S. D., Gallo, C., Laurentiis, M. D., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Mastro, L. D., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 11 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F. & Investigators, GIM., Apr 1 2018, In : The Lancet.Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 209 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Bisagni, G., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Cartenì, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'arco, A. M., D'auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, A., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P., Di Stefano, A., Diana, A., Donati, S., Fabbri, A., Fabi, A., Faedi, M., Farina, G., Farris, A., Febbraro, A., Fedele, P., Federico, P., Ferraù, F., Ferretti, G., Ferro, A., Floriani, I., Forcignanò, R., Forciniti, S., Forestieri, V., Fornari, G., Frisinghelli, M., Fusco, V., Gallizzi, G., Galvano, A., Gambardella, A., Gambi, A., Gebbia, V., Gervasi, E., Ghilardi, M., Giacobino, A., Giardina, G., Giotta, F., Giraudi, S., Giuliano, M., Grassadonia, A., Grasso, D., Grosso, F., Guizzaro, L., Incoronato, P., Incorvaia, L., Iodice, G., La Verde, N., Labonia, V., Landi, G., Latorre, A., Leonardi, V., Levaggi, A., Limite, G., Lina Bascialla, L., Livi, L., Maiello, E., Mandelli, D., Marcon, I., Menon, D., Montedoro, M., Moraca, L., Moretti, A., Morritti, M. G., Morselli, P., Mura, A., Mura, S., Musacchio, M., Muzio, A., Natale, D., Natoli, C., Nigro, C., Nisticò, C., Nuzzo, A., Orditura, M., Orlando, L., Pacilio, C., Palumbo, G., Palumbo, R., Pasini, F., Paterno, E., Pazzola, A., Pelliccioni, S., Pensabene, M., Perroni, D., Pesenti Gritti, A., Petrelli, F., Piccirillo, M. C., Pinotti, G., Pogliani, C., Poli, D., Prader, S., Recchia, F., Rizzi, D., Romano, C., Rossello, R., Rossini, C., Salvucci, G., Sanna, V., Santini, A., Saracchini, S., Savastano, C., Scambia, G., Schettini, F., Schiavone, P., Schirone, A., Seles, E., Signoriello, S., Signoriello, G., Silva, R. R., Silvestri, A., Simeon, V., Spagnoletti, I., Tamberi, S., Teragni, C., Thalmann, V., Thomas, R., Thomas, G., Tienghi, A., Tinari, N., Tinessa, V., Tomei, F., Tonini, G., Torri, V., Traficante, D., Tudini, M., Turazza, M., Vignoli, R., Vitale, M. G., Zacchia, A., Zagarese, P., Zanni, A., Zavallone, L., Zavettieri, M., Zoboli, A. & Investigators, GIM., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Impressive long-term response with pertuzumab and trastuzumab in HER2-positive breast cancer with brain metastasis

Russillo, M., Ferretti, G., Vidiri, A., Gasparro, S., Cognetti, F., Pellegrini, D. & Fabi, A., Jul 1 2018, In : In Vivo. 32, 4, p. 839-842 4 p.

Research output: Contribution to journalArticle

Brain Neoplasms
Brain
Breast Neoplasms
Neoplasm Metastasis
Oncology

Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients

Garassino, M. C., Gelibter, A. J., Grossi, F., Chiari, R., Soto Parra, H., Cascinu, S., Cognetti, F., Turci, D., Blasi, L., Bengala, C., Mini, E., Baldini, E., Quadrini, S., Ceresoli, G. L., Antonelli, P., Vasile, E., Pinto, C., Fasola, G., Galetta, D., Macerelli, M. & 3 others, Giannarelli, D., Lo Russo, G. & de Marinis, F., Aug 1 2018, In : Journal of Thoracic Oncology. 13, 8, p. 1146-1155 10 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Neoplasms
nivolumab
Population Control
Survival

Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients

Garassino, M. C., Gelibter, A. J., Grossi, F., Chiari, R., Soto Parra, H., Cascinu, S., Cognetti, F., Turci, D., Blasi, L., Bengala, C., Mini, E., Baldini, E., Quadrini, S., Ceresoli, G. L., Antonelli, P., Vasile, E., Pinto, C., Fasola, G., Galetta, D., Macerelli, M. & 3 others, Giannarelli, D., Lo Russo, G. & de Marinis, F., Aug 2018, In : Journal of Thoracic Oncology. 13, 8, p. 1146-1155 10 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Neoplasms
nivolumab
Population Control
Survival

Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients

Garassino, M. C., Gelibter, A. J., Grossi, F., Chiari, R., Parra, H. S., Cascinu, S., Cognetti, F., Turci, D., Blasi, L., Bengala, C., Mini, E., Baldini, E., Quadrini, S., Ceresoli, G. L., Antonelli, P., Vasile, E., Pinto, C., Fasola, G., Galetta, D., Macerelli, M. & 3 others, Giannarelli, D., Russo, G. L. & Marinis, F. D., Aug 1 2018, In : Journal of Thoracic Oncology. 13, 8, p. 1146-1155 10 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Neoplasms
nivolumab
Population Control
Survival